Imanis tumor cell lines are engineered for current oncology research. With reporter genes for tracking, thorough characterization, and tumor antigen modifications, these tumor cell lines provide the foundation needed to accelerate in vitro and in vivo pre-clinical therapy development.
Our xenograft and syngeneic tumor cell lines span hematological and solid cancers, with all lines expressing luciferase and/or eGFP for tumor tracking. Many are modified for key tumor-associated antigens — including BCMA, CD19, and CD20 — and all are in vivo-ready, with In Vivo Validated Models confirming growth in appropriate mouse models.
Get answers to common questions about lentiviral vectors
Don’t see what you need in our catalog? Our scientific team engineers custom cell lines and viral vectors, providing as much characterization data as you need to move forward with confidence.